LAB. FARMACEUTICOS ROVI, SA. secures contract for 1364/2025 - Invitation To The Presentation Of A Proposal For Direct Adjustment For The Acquisition Of, R1100 - Risperidone [75 Mg/0383 Ml; Susp Powder Inj Lp; Syringe], R1101 - Risperidone [100 Mg/0490 Ml; Susp Powder Inj Lp;

Portugal, Feb. 21 -- Portugal based LAB. FARMACEUTICOS ROVI, SA. has secured contract from Unidade Local De Saude Do Nordeste, E. P. E. for 1364/2025 - Invitation To The Presentation Of A Proposal For Direct Adjustment For The Acquisition Of, R1100 - Risperidone [75 Mg/0383 Ml; Susp Powder Inj Lp; Syringe], R1101 - Risperidone [100 Mg/0490 Ml; Susp Powder Inj Lp;. The value of the contract is worth 404271 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....